Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment
NB Abdol Razak, G Jones, M Bhandari, MC Berndt… - Cancers, 2018 - mdpi.com
Cancer-associated thrombosis is a major cause of mortality in cancer patients, the most
common type being venous thromboembolism (VTE). Several risk factors for developing …
common type being venous thromboembolism (VTE). Several risk factors for developing …
Mechanisms and biomarkers of cancer-associated thrombosis
Cancer-associated thrombosis is a leading cause of non-cancer death in cancer patients
and is comprised of both arterial and venous thromboembolism (VTE). There are multiple …
and is comprised of both arterial and venous thromboembolism (VTE). There are multiple …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Coagulation and inflammation in cancer: Limitations and prospects for treatment
The development of so-called immune checkpoint inhibitors (ICIs), which target specific
molecular processes of tumour growth, has had a transformative effect on cancer treatment …
molecular processes of tumour growth, has had a transformative effect on cancer treatment …
Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in patients
with cancer. Compared with the general population, cancer patients with VTE have higher …
with cancer. Compared with the general population, cancer patients with VTE have higher …
Meta‐analysis of VTE risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis
KS Weeks, E Herbach, M McDonald… - Obstetrics and …, 2020 - Wiley Online Library
Venous thromboembolisms (VTEs) have been a leading secondary cause of death among
ovarian cancer patients, prompting multiple studies of risk factors. The objective of this meta …
ovarian cancer patients, prompting multiple studies of risk factors. The objective of this meta …
[HTML][HTML] Right ventricular thrombus in transit: raising the stakes in the management of pulmonary embolism
E Lai, S Alishetti, JM Wong, L Delic, G Egrie… - CASE, 2019 - Elsevier
Discussion Right heart thrombus is an uncommon condition that is found in about 4% of
patients with pulmonary emboli. 1, 2 It is often found in transit, originating from a systemic …
patients with pulmonary emboli. 1, 2 It is often found in transit, originating from a systemic …
Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice
Cancer-associated venous thrombosis (CAT) is a common, multifactor event known to
complicate the course of cancer and jeopardize a patient's prognosis. The current guidelines …
complicate the course of cancer and jeopardize a patient's prognosis. The current guidelines …
[HTML][HTML] Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities
Advances in understanding the molecular mechanisms of tumor progression have achieved
impressive progress in the treatment of cancer and so-called immune checkpoint inhibitors …
impressive progress in the treatment of cancer and so-called immune checkpoint inhibitors …